Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Verici Dx Plc

VRCDF
Current price
0.03 USD 0 USD (0.00%)
Last closed 3.5 GBX
ISIN GB00BM8HZD43
Sector Healthcare
Industry Diagnostics & Research
Exchange LSE
Capitalization 8 827 524 GBX
Yield for 12 month -46.15 %
1Y
3Y
5Y
10Y
15Y
VRCDF
21.11.2021 - 28.11.2021

Verici Dx plc develops prognostic and diagnostic tests for kidney transplant patients. Its lead products are Tutivia, a post-transplant diagnostic test focused on acute cellular rejection, including sub-clinical rejection; and Clarava, a pre-transplant prognosis test for the risk of early acute rejection. The company is also developing Protega, a liquid biopsy to predict the risk of fibrosis and long-term graft failure. The company was incorporated in 2020 and is based in Cardiff, the United Kingdom. Address: Avon House, Cardiff, United Kingdom, CF64 2EZ

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

53.4 GBX

P/E ratio

Dividend Yield

Current Year

+78 402 553 GBX

Last Year

Current Quarter

+129 213 290 GBX

Last Quarter

+129 213 290 GBX

Current Year

+78 402 553 GBX

Last Year

Current Quarter

+129 213 290 GBX

Last Quarter

+129 213 290 GBX

Key Figures VRCDF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -3 757 053 GBX
Operating Margin TTM -43.52 %
PE Ratio
Return On Assets TTM -26.14 %
PEG Ratio
Return On Equity TTM -58.12 %
Wall Street Target Price 53.4 GBX
Revenue TTM 4 350 436 GBX
Book Value 0.044 GBX
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 17473.7 %
Dividend Yield
Gross Profit TTM
Earnings per share -0.02 GBX
Diluted Eps TTM -0.02 GBX
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin -110.99 %

Dividend Analytics VRCDF

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History VRCDF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation VRCDF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.0281
Price Sales TTM 2.0291
Enterprise Value EBITDA -1.574
Price Book MRQ 1.1167

Financials VRCDF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators VRCDF

For 52 weeks

3.07 GBX 13.05 GBX
50 Day MA 6.19 GBX
Shares Short Prior Month
200 Day MA 7.74 GBX
Short Ratio
Shares Short
Short Percent